Serum ASO Test Price and Booking at Chughtai Lab

Serum ASO Test at Chughtai Lab

The Serum Anti-Streptolysin O (ASO) test is a specialized immunological blood investigation designed to measure the concentration of antibodies produced by the human immune system in response to streptolysin O. Streptolysin O is an oxygen-labile, highly toxic extracellular enzyme released by Group A Streptococcus (Streptococcus pyogenes) bacteria. This bacterium is primarily responsible for common infections such as streptococcal pharyngitis (strep throat), scarlet fever, and various skin infections like impetigo. While most acute streptococcal infections are self-limiting or easily resolved with appropriate antibiotic therapy, some individuals may develop serious post-streptococcal sequelae. These delayed, non-suppurative complications include Acute Rheumatic Fever (ARF) and Post-Streptococcal Glomerulonephritis (PSGN). The Serum ASO test serves as a critical diagnostic tool to confirm a prior, often subclinical, Group A streptococcal infection in patients presenting with symptoms of these inflammatory complications.

Chughtai Lab, a premier diagnostic network in Pakistan, utilizes state-of-the-art automated immunoassay platforms and nephelometric techniques to perform quantitative Serum ASO testing. The primary clinical value of this test lies in its ability to provide retrospective evidence of a streptococcal infection. Because post-streptococcal complications typically manifest two to six weeks after the initial throat or skin infection, the bacteria are often no longer detectable via direct throat culture or rapid antigen detection tests (RADT). Consequently, serological evaluation of the patient’s immune response becomes the definitive method to establish a link between the current clinical presentation and a preceding streptococcal exposure. By measuring the titer of ASO antibodies in the blood serum, clinicians can evaluate the severity of the immune response, monitor the progression of post-streptococcal diseases, and differentiate streptococcal-induced inflammatory conditions from other autoimmune or infectious disorders.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure the clinical accuracy of the Serum ASO test results. Patients should adhere to the following guidelines prior to their appointment at Chughtai Lab:

• No Fasting Required: Fasting is generally not mandatory for a standalone Serum ASO test. Patients may consume food and water normally unless instructed otherwise by their physician due to concurrent tests.
• Medication Disclosure: It is critical to inform the healthcare provider and the laboratory staff of all medications currently being taken. Recent or ongoing antibiotic therapy can significantly suppress the immune response, leading to lower antibody production and potentially false-negative or blunted ASO titers.
• Immunosuppressive Drugs: Patients taking corticosteroids or other immunosuppressive agents should disclose this information, as these medications can alter antibody synthesis.
• Hydration: Adequate hydration is recommended prior to the blood draw, as it facilitates easier venipuncture and ensures optimal sample quality.

During the Procedure

The Serum ASO test is performed on a standard venous blood sample. The collection process at Chughtai Lab is conducted by highly trained phlebotomists adhering to strict aseptic protocols:

• Patient Positioning: The patient is seated comfortably, and the preferred arm is extended and supported.
• Site Selection: The phlebotomist identifies a suitable vein, typically the median cubital vein in the antecubital fossa (the crook of the elbow).
• Sanitization: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (such as 70% isopropyl alcohol) and allowed to air dry to prevent hemolysis of the sample.
• Tourniquet Application: A tourniquet is applied a few inches above the venipuncture site to increase venous pressure and make the vein more visible and palpable.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a gold-top serum separator tube or a red-top clot activator tube) is gently inserted into the vein.
• Sample Collection: The required volume of blood (usually 3 to 5 milliliters) is drawn into the tube. Once collection is complete, the tourniquet is released, and the needle is smoothly withdrawn.
• Post-Procedure Care: Gentle pressure is applied to the puncture site with a sterile cotton ball or gauze to promote hemostasis. An adhesive bandage is applied, and the patient is advised to keep it in place for at least 15 to 30 minutes. The entire procedure is virtually painless, with only a mild, brief pinching sensation during needle insertion, and takes less than five minutes.

When is a Serum ASO Test Performed?

Suspected Acute Rheumatic Fever

Physicians request a Serum ASO test when a patient, particularly a child or young adult, presents with clinical signs suggestive of Acute Rheumatic Fever (ARF). ARF is a multi-system inflammatory disease that can develop approximately two to four weeks after an untreated or inadequately treated Group A streptococcal pharyngitis. Clinical manifestations include carditis (inflammation of the heart muscle, valves, and surrounding membrane), migratory polyarthritis (severe, painful joint swelling that moves from one joint to another), Sydenham’s chorea (involuntary, rapid, jerky movements), erythema marginatum (a distinct skin rash), and subcutaneous nodules. Because these symptoms overlap with other rheumatological and infectious diseases, demonstrating a preceding streptococcal infection through an elevated or rising ASO titer is a mandatory criterion under the modified Jones Criteria for diagnosing ARF.

Post-Streptococcal Glomerulonephritis Evaluation

The test is highly indicated when a patient exhibits signs of acute kidney inflammation following a recent throat or skin infection. Post-Streptococcal Glomerulonephritis (PSGN) is an immunologically mediated glomerular injury characterized by the deposition of streptococcal antigen-antibody complexes within the renal glomeruli. Typical symptoms include hematuria (which may present as tea-colored or smoky urine), mild to moderate proteinuria, hypertension, oliguria (decreased urine output), and localized edema, particularly around the eyes (periorbital edema) and in the lower extremities. A Serum ASO test helps confirm that the glomerular damage is a direct sequela of a prior streptococcal infection, allowing clinicians to initiate appropriate supportive therapy and avoid unnecessary invasive procedures like renal biopsies in classic cases.

Unexplained Joint Pain and Migratory Polyarthritis

In pediatric and adult patients presenting with sudden, unexplained joint pain, the Serum ASO test is performed to rule out post-streptococcal reactive arthritis (PSRA) or early-stage rheumatic fever. Unlike classical rheumatoid arthritis or other chronic arthropathies, post-streptococcal joint involvement typically responds rapidly to anti-inflammatory therapy but requires careful monitoring to ensure that subclinical carditis is not present. Measuring ASO levels helps differentiate post-streptococcal arthritis from other acute arthritic conditions, such as septic arthritis, juvenile idiopathic arthritis, or viral-induced arthralgias, thereby guiding the long-term prophylactic antibiotic strategy.

Pediatric Autoimmune Neuropsychiatric Disorders (PANDAS)

The Serum ASO test is frequently utilized in the clinical evaluation of children who exhibit an abrupt, dramatic onset of obsessive-compulsive disorder (OCD) symptoms or tic disorders. This clinical phenomenon, known as Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS), is hypothesized to result from autoimmune cross-reactivity where streptococcal antibodies mistakenly target the basal ganglia of the brain. Clinicians order the ASO test, often in conjunction with anti-DNase B titers, to investigate whether a recent, perhaps asymptomatic, streptococcal infection served as the environmental trigger for the sudden onset of these neuropsychiatric symptoms.

Investigating Unresolved Post-Strep Complications

In cases where patients present with atypical symptoms, such as persistent low-grade fever, unexplained fatigue, or mild cardiac murmurs discovered during a routine physical examination, the Serum ASO test is performed to investigate the possibility of an unrecognized, resolving streptococcal infection. Identifying elevated antibody levels in these patients prompts a more thorough cardiac evaluation, including an echocardiogram, to detect subclinical valvular damage (rheumatic heart disease) that may require long-term penicillin prophylaxis to prevent recurrent streptococcal infections and cumulative cardiac injury.

What Does a Serum ASO Test Detect?

The Serum ASO test detects and quantifies specific antibodies in the blood. The following points outline the clinical findings and interpretations associated with this diagnostic investigation:

• Normal Baseline Levels: A normal or low ASO titer (typically less than 200 IU/mL in adults and less than 150 IU/mL in children) indicates the absence of a recent Group A streptococcal infection.
• Elevated Antibody Levels: An elevated ASO titer (greater than 200 IU/mL in adults) indicates a recent or past exposure to Group A Streptococcus.
• Active Infection Confirmation: A single elevated titer suggests a recent infection but must be interpreted alongside clinical symptoms.
• Serial Titer Trends: A twofold or greater increase in ASO titers when tested 10 to 14 days apart confirms an active, acute, or very recent streptococcal infection.
• Peak Antibody Response: ASO antibody levels typically begin to rise 1 to 3 weeks after the initial infection, peak at 3 to 8 weeks, and then gradually decline.
• Resolving Infection: A downward trend in serial ASO titers indicates a resolving immune response and a past infection that is clearing.
• Persistent Elevation: Persistently high ASO levels over several months can occur in some individuals, reflecting a prolonged immune response or recurrent exposure.
• False-Negative in Early Phase: Testing too early (within the first week of infection) may yield a normal result before the immune system has produced detectable antibody levels.
• Antibiotic Suppression: Early administration of antibiotics can blunt the antibody response, resulting in low or normal ASO levels despite a genuine infection.
• Skin Infection Limitations: Patients with streptococcal skin infections (impetigo) often do not produce high ASO titers; an anti-DNase B test is preferred in these cases.
• False-Positive from Liver Disease: Patients with active hepatitis or other severe liver disorders may show elevated ASO levels due to non-specific hypergammaglobulinemia.
• Lipid Interference: High concentrations of beta-lipoproteins in the blood serum can cause false-positive elevations in ASO titers.
• Bacterial Contamination: Contamination of the serum sample can lead to false-positive results due to the production of streptolysin-like substances by other bacteria.
• Rheumatic Heart Disease Correlation: Very high ASO titers are strongly associated with active carditis in patients with Rheumatic Fever.
• Glomerulonephritis Association: Elevated ASO levels in a patient with hematuria and edema support a diagnosis of Post-Streptococcal Glomerulonephritis.
• Sydenham’s Chorea Detection: Patients presenting with chorea may have declining or near-normal ASO titers because chorea often manifests months after the initial infection.
• Scarlet Fever Confirmation: Elevated titers help confirm a diagnosis of scarlet fever in patients presenting with a characteristic strawberry tongue and sandpaper rash.
• Erythema Nodosum Link: The test can identify a streptococcal etiology in patients presenting with erythema nodosum (painful red nodules on the shins).
• Toxic Shock Syndrome Evaluation: Elevated ASO levels can support the diagnosis of streptococcal toxic shock syndrome in critically ill patients.
• PANDAS Diagnostic Support: High titers in pediatric patients with sudden-onset tics provide supportive evidence for a PANDAS diagnosis.
• Asymptomatic Carrier State: Asymptomatic streptococcal carriers in endemic areas may exhibit moderately elevated baseline ASO titers without active disease.
• Non-Group A Reactivity: The test may occasionally detect infections caused by Group C or Group G Streptococcus, which also produce streptolysin O.
• Inflammatory Marker Correlation: Elevated ASO titers are often evaluated alongside elevated Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) levels.
• Normal Levels in Non-Strep Arthritis: Normal ASO titers help rule out streptococcal involvement in patients with rheumatoid arthritis or gout.
• Long-Term Monitoring: Monitoring ASO titers helps assess the efficacy of prophylactic antibiotic therapy in preventing recurrent rheumatic fever.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to providing rapid, accurate, and highly accessible diagnostic services. The turnaround time (TAT) for a quantitative Serum ASO test is typically within 12 to 24 hours from the time of sample collection. Because Chughtai Lab utilizes fully automated, high-throughput analyzers, processing is streamlined to minimize human error and expedite reporting.

Once the analysis is complete and verified by a consultant pathologist, patients are notified via an automated SMS. Reports can be accessed and downloaded digitally through multiple convenient channels, including the official Chughtai Lab website portal, the Chughtai Lab mobile application, and directly via WhatsApp. Physical copies of the report can also be collected from any of Chughtai Lab’s numerous collection centers located across Pakistan, ensuring a seamless experience for patients and referring physicians alike.

Serum ASO Test Findings Overview

The following table provides an overview of the parameters evaluated during a Serum ASO test, comparing normal and abnormal clinical findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Adult ASO Titer	Less than 200 IU/mL	Equal to or greater than 200 IU/mL (indicates recent streptococcal exposure)
Pediatric ASO Titer	Less than 150 IU/mL	Equal to or greater than 150 IU/mL (suggests recent infection in children)
Serial Titer Trend (10-14 days apart)	Stable or declining titers	Twofold or greater increase (confirms acute, active streptococcal infection)
Erythrocyte Sedimentation Rate (ESR)	0 to 15 mm/hr (men); 0 to 20 mm/hr (women)	Elevated (indicates active systemic inflammation, common in ARF)
C-Reactive Protein (CRP)	Less than 5.0 mg/L	Elevated (indicates acute inflammatory response)
Urinalysis (for PSGN evaluation)	Negative for protein and red blood cells	Hematuria, red blood cell casts, and proteinuria (indicates glomerular injury)
Serum Complement C3 Level	80 to 160 mg/dL	Decreased levels (indicates immune complex consumption in active PSGN)
Anti-DNase B Titer	Normal range based on age	Elevated (highly sensitive for confirming prior streptococcal skin infections)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Serum ASO Test?

• Advanced Automated Technology: Chughtai Lab utilizes state-of-the-art, fully automated nephelometric and turbidimetric platforms to ensure the highest precision in antibody quantification.
• ISO 15189 Certification: The laboratory operates under strict international quality management standards, ensuring reliable and reproducible test results.
• Expert Pathologist Supervision: Every test is conducted under the direct supervision of highly qualified, board-certified clinical pathologists.
• Convenient Home Sample Collection: Chughtai Lab offers professional home blood collection services across all major cities in Pakistan, bringing quality diagnostics to your doorstep.
• Rapid Turnaround Time: Results are processed efficiently, with most reports available within 12 to 24 hours of sample receipt.
• Seamless Digital Access: Patients can easily view, download, and share their reports via the Chughtai Lab mobile app, official website, or WhatsApp.
• Extensive Network: With hundreds of collection centers nationwide, accessing diagnostic services is convenient and hassle-free.
• Patient-Centric Care: Chughtai Lab prioritizes patient comfort, safety, and confidentiality, providing a professional and welcoming environment at all facilities.